Emerging Cellular Therapies: T Cells and Beyond

The field of cellular therapies against cancer and chronic infections is advancing rapidly due to a deepening understanding of cell biology. New technologies permit efficient cell culture, gene transfer and genetic editing, enabling autologous and allogeneic cell therapy. With rapid development of CAR T cells, breakthrough FDA approval status, and fast-tracking clinical trials, competition is fierce in the biotechnology and pharmaceutical industries. Cell therapies with stem cells and T cells are in advanced clinical development that will enable widespread use for cancer and chronic infections such as HIV.

If you are interested in meeting a CARAT partner, Martin Pule of UCL is giving a talk on “New Designs in Synthetic T Cells” on Wednesday, February 14 in the Session “Beyond T Cells: HSC, T Progenitor, and IPSCs I” (17.00 – 19:00).

More information on the event can be found on the website.